Invest
Tools
Holidays
More
Trade
Tools
Learning Center
Help Center
Resources
About Us
Market News
6 min read | Updated on July 01, 2026, 10:41 IST
SUMMARY
NIFTY50 and SENSEX underperformed in the first half of 2026 as US trade tariffs, Middle East conflict, FIIs sell-off and crude price rise impacted the market sentiments. Despite weak market performance, several midcap stocks like Sterlite Technologies, Garware Hi-Tech, Rubicon Research, Mtar Technologies and others delivered returns of 100% and more to investors.
Stock list
Telecom infrastructure stocks Sterlite Technologies and HFCL outperform amid rising demand from AI infrastructure and data centres.
NIFTY50, SENSEX and the overall Indian stock market performance in the first half of 2026 were heavily dictated by multiple events. NIFTY50 and SENSEX are down 8.6% and 10.2% as of June 30, 2026, amid several global and domestic headwinds.
The first half of 2026 saw US trade tariffs that disrupted the global supply chain, followed by the US-Israel-Iran war. Military action in the Middle East region impacted the crude oil supplies. As a result, crude oil prices surged to record high levels. Meanwhile, AI and AI-related stocks grab investors' attention, especially in the US and South Korean markets, despite several headwinds.
In the domestic markets, record FIIs sell-off, decline in traditional IT stocks due to AI demand, rupee depreciation and crude oil spike made investors' sentiments weak.
Despite these headwinds, some of the stocks went against the tide and delivered strong returns to their investors.
Sterlite Technologies and HFCL emerged as the top-performing stocks in the first half of 2026, with returns of 494% and 214% supported by strong industry tailwinds and company-specific growth. Rising investment in AI infrastructure and data centres in India increased demand for fibre-optic cables and high-speed connectivity solutions offered by these companies. Besides this, the 5G network rollout in India increased orders for telecom equipment and optical fibre products.
Both companies reported strong order books and improved financial performance. In FY26, Sterlite Technologies' consolidated revenue rose 18.8% YoY to ₹4,745 crore, while the company turned profitable with net profit after tax of ₹56 crore compared to a loss of ₹123 crore in FY25. Meanwhile, HFCL reported consolidated revenue of ₹4,949 crore (up 21.7% YoY) and a net profit of ₹329 crore (90.1% YoY).
MTAR Technologies shares delivered a 215% return to its investors so far in 2026. The company benefited from robust demand from the aerospace, defence, clean energy and nuclear sectors. Investors rewarded the company for its healthy order book and long-term growth visibility. Rising investments by the government in energy transition projects like hydrogen and nuclear power are positive for the company as it manufactures several equipment related to clean energy.
In FY26, the company reported consolidated revenue from operations of ₹876 crore, up 29.5% YoY, while net profit jumped 75.9% YoY to ₹95 crore.
Electronic segment companies Aditya Infotech and Avalon Technologies delivered YTD returns of 144% and 105%. Rising demand for surveillance systems and smart security solutions boosted the order book and business of Aditya Infotech, which operates the flagship brand CP PLUS. Avalon Technologies gained from growing orders for electronic manufacturing services (EMS) and the push for domestic manufacturing through schemes like Make in India and Production Linked Incentive (PLI).
In FY26, Aditya Infotech reported robust financial performance, with total revenue rising 35.6% YoY to ₹4,221 crore, while its net profit stood at ₹368 crore, up 4.8% YoY. Meanwhile, Avalon Technologies reported consolidated revenue of ₹1,603 crore (up 45.9% YoY) and a net profit of ₹113 crore, up 79.3% YoY.
Pharma company Rubicon Research and Hospital chain operator Park Medi World delivered 105% and 104% returns to investors in the first six months of 2026. Park Medi World stock gained supported by robust FY26 earnings and expansion of its hospital network. In May 2026, the company successfully acquired a 100% stake in The Medicity Hospital in Rudrapur for ₹177 crore, expanding its footprint to 17 hospitals. In FY26, Park Medi World's revenue rose 20.4% YoY to ₹1,679 crore, while net profit jumped 28.6% YoY to ₹274 crore.
Rubicon Research stock benefited from rising demand for generic medicines in regulated markets such as the US and Europe. The pharma company also posted robust FY26 earnings with its profit after tax (PAT) rising 84.3% YoY to ₹247 crore, while revenue from operations rose 36.6% YoY to ₹1,754 crore.
Garware Hi-Tech and Acutaas Chemicals delivered 114% and 106% returns so far in 2026 due to favourable industry trends and rising demand for speciality products, which offer higher profit margins than commodity products. Besides this strong export demand, rising sales and improved margins also supported the stock performance.
The stock discussed in this article is only for educational purposes and not a buy or sell recommendation. Investors are advised to conduct their own analysis and risk due diligence before trading and investing in the stock market. Investments in the securities market are subject to market risk. Read all the related documents carefully before investing.
About The Author
Next Story
What is the Nifty Insurance Index? Constituents, Historical Returns, and Selection Criteria
What is the Nifty Sugar and Ethanol Index? Components, Returns, and Selection Criteria
What is the Nifty NBFC Index? Constituents, Historical Performance, and Selection Criteria
Explore Learning Centre
All topics · stocks, MFs, derivatives, IPOs
Upstox Securities Pvt. Ltd.: SEBI Registration No. INZ000315837 | NSE TM Code: 13942 | BSE TM Code: 6155 | CDSL Reg No.: IN-DP-761-2024 | CIN: U65100DL2021PTC376860 | Compliance Officer: Mr. Kapil Jaikalyani. Tel No.: (022) 24229920. Email ID: compliance@upstox.com | Registered Address: 809, New Delhi House, Barakhamba Road, Connaught Place, New Delhi – 110001 | RKSV Commodities India Pvt. Ltd.: SEBI Registration No.: INZ000015837 | MCX TM Code: 46510 | CIN: U74900DL2009PTC189166 | Compliance Officer: Mr. Amit Lalan. Tel No.: (022) 24229920. Email ID: compliance@rksv.in | Registered Address: 807, New Delhi House, Barakhamba Road, Connaught Place, New Delhi – 110001. Correspondence Address: 30th Floor, Sunshine Tower, Senapati Bapat Marg, Dadar (West), Mumbai – 400013. | For any complaints, email at complaints@upstox.com and complaints.mcx@upstox.com.
Procedure to file a complaint on SEBI SCORES: Register on the SCORES portal. Mandatory details for filing complaints on SCORES include: Name, PAN, Address, Mobile Number, and E-mail ID. Benefits include effective communication and speedy redressal of grievances. Please ensure you carefully read the Risk Disclosure Document as prescribed by SEBI, along with our Terms of Use and Privacy Policy.
Upstox Securities Private Limited is a wholly owned subsidiary of RKSV Securities India Private Limited and RKSV Commodities India Private Limited is an associate of RKSV Securities India Private Limited.
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing.
*Brokerage will not exceed the SEBI prescribed limit.
Mutual Funds: Top rated funds do not constitute any advice. Research data is powered by Morningstar. Please read the offer documents carefully before investing. Upstox shall not accept any liability arising out of your investments.
These are not Exchange traded products, and the Member is just acting as distributor. All disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism.
Attention Investors: As per NSE circular dated July 6, 2022, BSE circular dated July 6, 2022, MCX circular dated July 11, 2022 investors are cautioned to abstain them from dealing in any schemes of unauthorised collective investments/portfolio management, indicative/ guaranteed/fixed returns / payments etc. Investors are further cautioned to avoid practices like:
a) Sharing i) trading credentials – login id & passwords including OTP’s., ii) trading strategies, iii) position details.
b) Trading in leveraged products /derivatives like Options without proper understanding, which could lead to losses.
c) Writing/ selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
d) Dealing in unsolicited tips through platforms like Whatsapp, Telegram, Instagram, YouTube, Facebook, SMS, calls, etc.
e) Trading / Trading in “Options” based on recommendations from unauthorised / unregistered investment advisors and influencers.
Kindly, read the Advisory Guidelines For Investors as prescribed by the Exchange with reference to their circular dated 27th August, 2021 regarding investor awareness and safeguarding client’s assets: Advisory Guidelines For Investors
Kindly, read the advisory as prescribed by the Exchange with reference to their circular dated January 14, 2022 regarding Updation of mandatory KYC fields by March 31, 2022: KYC Updation
Attention Investors: Prevent unauthorised transactions in your Demat account by updating your mobile number with your depository participant. Receive alerts on your registered mobile number for debit and other important transactions in your Demat account directly from CDSL on the same day. Prevent unauthorised transactions in your Trading account by updating your mobile numbers/email addresses with your stock brokers. Receive information on your transactions directly from the Exchange on your mobile/email at the end of the day. Issued in the interest of investors. KYC is a one-time exercise while dealing in securities markets – once KYC is done through a SEBI-registered intermediary (broker, DP, Mutual Fund, etc.), you need not undergo the same process again when you approach another intermediary. As a business, we don’t give stock tips and have not authorised anyone to trade on behalf of others. If you find anyone claiming to be part of Upstox or RKSV and offering such services, please send us an email at complaints@upstox.com and complaints.mcx@upstox.com.
No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account. Stockbrokers can accept securities as margin from their clients only by way of a pledge in the depository system w.e.f. 1st September 2020.
Update your email ID and mobile number with your stockbroker/depository participant and receive an OTP directly from the depository on your registered email ID and/or mobile number to create a pledge.
Check your securities/mutual funds/bonds in the Consolidated Account Statement (CAS) issued by NSDL/CDSL every month.
Attention Investors: SEBI has established an Online Dispute Resolution Portal (ODR Portal) for resolving disputes in the Indian Securities Market. This circular streamlines the existing dispute resolution mechanism, offering online conciliation and arbitration, benefiting investors and listed companies. https://www.sebi.gov.in/legal/circulars/jul-2023/online-resolution-of-disputes-in-the-indian-securities-market_74794.html ODR portal for Investors – https://smartodr.in/login
Leave a Reply